Trial Profile
Phase I Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Resistant Solid Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Temsirolimus (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jun 2012 Actual patients number is 28 as reported by ClinicalTrials.gov.
- 22 Jun 2012 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.